Solu-cortef Injection, Powder, For Solution
Product Images NDC 0009-0825

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Solu-cortef (NDC 0009-0825). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmacia & Upjohn Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Solu Cortef 01)

Chemical structure diagram of hydrocortisone sodium succinate, the active ingredient in Solu-Cortef injection powder for solution. The diagram depicts the molecular configuration with labeled functional groups and atomic bonds.*

FDA Label Image

Image (Solu Cortef 02)

An instructional diagram showing a cross-sectional view of a container or device with a needle inserted into it. The illustration likely demonstrates a method of accessing or drawing solution from the container, relevant to the Solu-Cortef injection preparation.*

FDA Label Image

Logo (Solu Cortef 03)

FDA Label Image

Principal Display Panel (100 mg Vial Label)

Label for Solu-Cortef 100 mg/vial injection powder for solution. The product contains hydrocortisone sodium succinate equivalent to 100 mg hydrocortisone per vial. It is preservative-free and intended for intramuscular or intravenous use. Distributor is Pharmacia & Upjohn Co, a division of Pfizer Inc, NY, NY.*

FDA Label Image

Principal Display Panel (100 mg Vial Carton)

Packaging label for Solu-Cortef 100 mg/vial (hydrocortisone sodium succinate) injection powder for solution. The label indicates the product is for intramuscular or intravenous use, preservative-free, and distributed by Pharmacia & Upjohn Company LLC, a division of Pfizer Inc. It includes storage instructions, dosage details, and the Pfizer Injectables logo.*

FDA Label Image

Principal Display Panel (100 mg Single-Dose Vial Label)

Label for Solu-Cortef injection, powder for solution, containing hydrocortisone sodium succinate equivalent to 100 mg per 2 mL vial. The label indicates the product is preservative-free, for intramuscular or intravenous use, distributed by Pharmacia & Upjohn Co., a Pfizer division. It includes dosage instructions to consult prescribing information and notes to protect the solution from light and discard after 3 days once reconstituted.*

FDA Label Image

Principal Display Panel (100 mg Single-Dose Vial Carton)

Box packaging label for Solu-Cortef 100 mg/vial (hydrocortisone sodium succinate) injection powder for solution by Pharmacia & Upjohn Company LLC, a division of Pfizer. The label states the drug is for intramuscular or intravenous use and is preservative-free. Instructions for storage and directions for using the Act-O-Vial system are included. The package contains 25 single-dose vials of 2 mL each.*

FDA Label Image

Principal Display Panel (250 mg Single-Dose Vial Label)

Label for Solu-Cortef 250 mg/vial injection powder for solution, hydrocortisone sodium succinate, 2 mL single-dose vial. Distributed by Pharmacia & Upjohn Company LLC, Division of Pfizer Inc. Dosage and use instructions indicate lyophilized powder for IM or IV use, preservative-free.*

FDA Label Image

Principal Display Panel (250 mg Single-Dose Vial Carton)

Packaging label for Solu-Cortef 250 mg/vial (hydrocortisone sodium succinate) injection powder for solution in a 2 mL single-dose vial. The label indicates intramuscular or intravenous use, preservative-free formulation, and includes directions for use with the Act-O-Vial system. Distributed by Pharmacia & Upjohn Co, division of Pfizer Inc.*

FDA Label Image

Principal Display Panel (500 mg Single-Dose Vial Label)

Label for Solu-Cortef 500 mg/vial injection powder for solution, hydrocortisone sodium succinate, provided in a 4 mL single-dose vial by Pharmacia & Upjohn Company LLC. The label includes storage instructions, dosage guidance, and states the product is preservative-free for intramuscular or intravenous use.*

FDA Label Image

Principal Display Panel (500 mg Single-Dose Vial Carton)

Solu-Cortef 500 mg/vial (hydrocortisone sodium succinate) injection powder for solution by Pharmacia & Upjohn Company LLC, labeled for intramuscular or intravenous use. The single-dose vial packaging is preservative-free and displays directions for use, storage instructions, and the Pfizer Injectables logo. The carton includes barcode and lot/expiration imprint area.*

FDA Label Image

Principal Display Panel (1000 mg Single-Dose Vial Label)

Solu-Cortef 1000 mg/vial injection powder label for an 8 mL single-dose vial containing hydrocortisone sodium succinate. The label includes storage instructions, usage notes, and states it is preservative-free for intramuscular or intravenous use. Distributed by Pharmacia & Upjohn Company LLC.*

FDA Label Image

Principal Display Panel (1000 mg Single-Dose Vial Carton)

Packaging label for Solu-Cortef 1000 mg/vial (hydrocortisone sodium succinate) injection powder for solution, USP in a single-dose 8 mL Act-O-Vial. The label indicates it is for intramuscular or intravenous use, preservative-free, and manufactured by Pharmacia & Upjohn Company LLC, a division of Pfizer Inc. The label includes dosage and use instructions and storage conditions at controlled room temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.